HemeTalks: Conversations in Hematology Education is an American Society of Hematology (ASH) podcast for community hematologists, advanced practice providers, and trainees. Through engaging storytelling and case-based discussions with guests ranging from early-career professionals to leading experts, the podcast offers practical strategies that make complex hematology topics accessible and relevant at every career stage. Its mission is to support the educational needs of its audience through high-quality, clinically focused content.
HemeTalks: Conversations in Hematology Education
Claim This Podcastby American Society of Hematology
5.0(5 reviews)
35 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
15
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality16
Social0
YouTube0
Engagement32
Podcast Overview
HemeTalks: Conversations in Hematology Education is an American Society of Hematology (ASH) podcast for community hematologists, advanced practice providers, and trainees. Through engaging storytelling and case-based discussions with guests ranging from early-career professionals to leading experts, the podcast offers practical strategies that make complex hematology topics accessible and relevant at every career stage. Its mission is to support the educational needs of its audience through high-quality, clinically focused content.
Language
🇺🇲
Publishing Since
6/7/2023
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
15
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality16
Social0
YouTube0
Engagement32
6
Excellent Areas
2
Good Performance
11
Growth Opportunities
excellent
Episode Length
22 minutes
Performing excellently!
good
Show Experience
24 episodes over 2.2 years
Recommendations available
Unlock the full report to see detailed tips
poor
Publishing Consistency
Every 34 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for HemeTalks: Conversations in Hematology Education
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 21, 2026
Multiple Myeloma Care: Timing, Teamwork, Treatment
<p>Multiple myeloma care is evolving faster than ever, with new therapies, treatment strategies, and possibilities emerging at an unprecedented pace. In this episode, hematologist Dr. Devarakonda and Kathy Giusti, founder of the Multiple Myeloma Research Foundation, come together for a candid, practical conversation about what this rapid progress means for patients, caregivers, and providers.</p><p>They explore why where you’re treated matters, how timing, sequencing, and dosing decisions shape outcomes, and what it takes to be an informed patient in today’s complex care environment. Through real-world stories and clinical insight, the conversation highlights the importance of collaboration between community and academic care teams, the growing role of the patient voice in decision-making, and the need to balance cutting-edge treatment with quality of life.</p><p>Whether newly diagnosed or navigating later lines of therapy, this episode offers practical guidance for making confident, informed decisions in multiple myeloma care.</p><p><strong>Key Takeaways</strong></p><ul><li><strong>Multiple myeloma is increasingly treatable, with patients living longer than ever<br></strong>Advances in therapy are leading to remission for many patients and significantly improving survival outcomes.</li><li><strong>Where you’re treated—and your care team—matters more than ever<br></strong>The most effective care is team-based, involving academic specialists, community oncologists, and the patient along with their caregiver working together.</li><li><strong>Treatment decisions are more complex: timing, sequencing, and dosing all matter<br></strong>With a growing number of options, patients and providers must navigate when and how to use therapies through ongoing, informed discussions.</li><li><strong>Being informed is essential to navigating care today<br></strong>Patients have more access to information than ever before, and using that information effectively supports shared decision-making with their care team.</li></ul>
May 21, 2026
Atención del Mieloma Múltiple: Oportunidad, Trabajo en Equipo y Tratamiento
<p>La atención del mieloma múltiple está evolucionando más rápido que nunca, con la aparición de nuevas terapias, estrategias de tratamiento y posibilidades a un ritmo sin precedentes. En este episodio, el hematólogo Dr. Devarakonda y Kathy Giusti, fundadora de la Multiple Myeloma Research Foundation (Fundación para la Investigación del Mieloma Múltiple), se reúnen en una conversación sincera y práctica sobre lo que este rápido avance significa para los pacientes, sus cuidadores y el personal de salud.</p><p>Ambos analizan por qué el lugar donde recibes el tratamiento es crucial, cómo las decisiones sobre el momento oportuno, la secuencia y las dosis de los medicamentos definen los resultados, y qué se necesita para ser un paciente informado en el complejo entorno de salud actual. A través de historias reales y una visión clínica, la conversación resalta la importancia de la colaboración entre los oncólogos locales y los centros médicos de alta complejidad, el rol cada vez mayor de la voz del paciente en la toma de decisiones, y la necesidad de equilibrar los tratamientos de vanguardia con la calidad de vida.</p><p>Ya sea que enfrentes un diagnóstico reciente o estés navegando por opciones para etapas más avanzadas de la enfermedad, este episodio ofrece una guía práctica para tomar decisiones seguras e informadas en la atención del mieloma múltiple.</p><p><strong>Puntos clave</strong></p><ul><li><strong>El mieloma múltiple es cada vez más tratable y los pacientes viven más tiempo que nunca</strong><br>Los avances terapéuticos están logrando la remisión en muchos pacientes y mejorando significativamente las tasas de supervivencia.</li><li><strong>El lugar donde te tratas —y tu equipo médico— importa más que nunca</strong><br>La atención más eficaz es la que se realiza en equipo, donde colaboran los especialistas académicos, los oncólogos de la comunidad, y el paciente junto a su cuidador trabajando de manera conjunta.</li><li><strong>Las decisiones de tratamiento son más complejas: el momento, la secuencia y las dosis son factores clave</strong><br>Con un número creciente de opciones, los pacientes y los médicos deben evaluar cuándo y cómo utilizar las terapias mediante un diálogo continuo e informado.</li><li><strong>Estar informado es esencial para gestionar tu atención hoy en día</strong><br>Los pacientes tienen más acceso a la información que nunca; utilizarla de manera eficaz facilita la toma de decisiones compartidas con su equipo médico.</li></ul>
May 7, 2026
TTP Today: Diagnosis, Management & Evolving Therapies
<p>TTP is a hematologic emergency that demands immediate recognition and treatment to prevent fatal outcomes. In this HemeTalks episode, Dr. Yazan Abou-Ismail and Dr. Kolton Smith discuss the diagnostic hallmarks, therapeutic advances, and follow-up strategies for patients with TTP.</p><p>Through the lens of a clinical case, they explore the impact of caplacizumab, the importance of ADAMTS13 testing, and how to differentiate TTP from other TMAs. Tune in for practical insights that every hematologist and frontline provider should know.</p><p><strong>Learning Objectives:</strong></p><ol><li>Recognize clinical and laboratory features indicative of TTP.</li><li>Understand the evolving treatment landscape, including the role of caplacizumab.</li><li>Apply principles for acute and chronic management of both congenital and acquired TTP.</li></ol><p><strong>Clinical Pearls:</strong></p><ol><li>Always consider iTTP diagnosis in any patient with findings of thrombotic microangiopathy, as early recognition is critical.</li><li>When iTTP is suspected, it is essential to start empiric therapy immediately—untreated disease carries a high mortality risk.</li><li>Monitor closely for disease exacerbation or relapse even after initial clinical response is achieved.</li></ol>
35 total episodes available
Recent guests on HemeTalks: Conversations in Hematology Education
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Richard Burwick
Guest
Shruti Chaturvedi
Guest
Dr Margo Rollins
Guest
experts from cellular therapy and bone marrow transplantation (BMT)
Guest
Similar Podcasts
Discover related shows you might enjoy
Two Onc Docs
Sam and Karine
Blood Podcast
American Society of Hematology
The Hematologist
The Hematologist
Harrison's PodClass: Internal Medicine Cases and Board Prep
AccessMedicine
JAMA Clinical Reviews
JAMA Network
Core IM | Internal Medicine Podcast
Core IM Team
The Clinical Problem Solvers
The Clinical Problem Solvers
Ninja Nerd
Ninja Nerd
Annals On Call Podcast
American College of Physicians
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
NEJM This Week
NEJM Group
The Curious Clinicians
The Curious Clinicians
The Oncology Nursing Podcast
Oncology Nursing Society
Blood Cancer Talks
Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
Plenary Session
Vinay Prasad, MD MPH
Deep-dive analytics for HemeTalks: Conversations in Hematology Education
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is HemeTalks: Conversations in Hematology Education?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.